For several years now, anticoagulant drugs Pradaxa and Xarelto have been linked with serious bleeding events, some of which have caused hospitalizations and even death. The courts have been busy processing lawsuits filed by injured plaintiffs who claim manufacturers overstated the benefits of these
On April 3, 2015, a Montana couple filed a new Zofran lawsuit against manufacturer GlaxoSmithKline (GSK), claiming the anti-nausea drug caused their daughter to be born with a cleft lip and palate. The case is pending in the U.S. District Court of Montana, Billings Division.…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana on December 12, 2014. At the time, 21 cases were transferred from ten districts to Louisiana. Since then, many more have joined the…
On March 6, 2015, an Oakland, California mom filed a new Zofran lawsuit against manufacturer GlaxoSmithKline, LLC (GSK). The plaintiff claims that because she took the anti-nausea medication during pregnancy, her young son was born with a serious heart defect. She seeks compensation for medical…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. Judge Eldon E. Fallon was appointed to oversee the proceedings. Currently, over 400 cases are pending in the Xarelto MDL,…
On April 1, 2015, an Alabama woman filed a new Zofran lawsuit on behalf of herself and her young son. The plaintiff claims that because she was prescribed Zofran during her first trimester of pregnancy, her son suffers from a number of birth defects that…
The most recent status conference concerning the Xarelto MDL, currently proceeding in the Eastern District of Louisiana, took place on April 1, 2015. The U.S. Judicial Panel on Multidistrict Litigation (JPML) established the MDL in December 2014. According to minutes from the meeting, both the…
The FDA approved the use of Xarelto (rivaroxaban) in 2011 for reducing the risk of blood clots in patients undergoing knee and hip replacement surgery, and later that same year for reducing the risk of blood clots and stroke in patients with non-valvular atrial fibrillation.…
On March 20, 2015, Tennessee resident Danny Julian filed a Xarelto wrongful death lawsuit on behalf of his father, Tommy Julien. The Plaintiff claims that his father died after using the anticoagulant drug. He names manufacturers Bayer Healthcare Pharmaceuticals, Janssen Pharmaceuticals, and parent
When manufacturers first released Xarelto on the market in 2011, they advertised it as a more convenient alternative to the leading blood-thinner, warfarin. Approved for reducing the risk of blood clots following knee or hip replacement surgery, as well as to reduce risk of stroke…
According to a recent study published in Obstetrics & Gynecology, dangers associated with power morcellation in gynecological surgeries may extend beyond increasing the risk of aggressive cancers. In April 2014, the FDA warned that use of the power morcellation tool during surgery for uterine fibroi
Many plaintiffs filing Risperdal lawsuits have claimed that the anti-psychotic drug caused gynecomastia (unusual breast enlargement) in young boys. A number of studies have found this connection, including a 2006 study that reported some children and adolescents taking the medication experienced ele
